Â
Professor & Head, Department of Nephrology
Government Stanley Medical College and Hospital , Chennai
Dr. Edwin Fernando is a prominent nephrologist and the Professor & Head of the Department of Nephrology at Government Stanley Medical College and Hospital in Chennai. His academic and research interests are focused on advancing clinical practices in renal care, specifically within the Indian healthcare context. He is one of the key persons to work on Community acquired AKI registry in India.
He has done extensive studies in Transplantation and Nephro pathology.
A 34 year-old male is admitted in a hospital with 6 days history of high-grade fever, severe myalgia, vomiting, and progressive oliguria. He works in municipal flood-cleaning operations and reports exposure to stagnant water. On arrival, he is hypotensive requiring noradrenaline, icteric, and mildly confused. There is conjunctival suffusion and diffuse muscle tenderness.
Laboratory evaluation reveals rising creatinine from 1.1 mg/dL (documented 1 year ago) to 4.8 mg/dL over 48 hours. Platelets are 46,000/µL, bilirubin 10 mg/dL (direct predominant), Creatine Kinase 12,000 IU/L, LDH 542 U/L, Potassium 5.9 mmol/L, lactate 6 mmol/L, and INR 2.1. Urine dipstick is strongly positive for blood, yet microscopy shows minimal RBCs. Chest imaging shows patchy infiltrates. Tropical fever panel has been sent.
The ICU team confronts overlapping possibilities—leptospirosis, severe malaria, dengue with capillary leak, scrub typhus, rhabdomyolysis, evolving TMA—each capable of causing AKI through distinct pathophysiologic mechanisms. Management decisions must precede diagnostic certainty, and early choices may determine reversibility.
(Click / Tap on Questions to Reveal Content)
Tropical AKI arises from diverse endemic causes in tropical regions, such as infections (e.g., malaria, leptospirosis, dengue), toxins (e.g., snakebites, paraquat), and obstetric complications, often compounded by hypovolemia from heat and malnutrition. Its pathophysiology varies widely by etiology—ranging from hypovolemia and direct tubular toxicity in leptospirosis (non-oliguric with interstitial nephritis) to cytoadherence in malaria or rhabdomyolysis from snake venom—leading to heterogeneous renal injury patterns beyond pure acute tubular necrosis. Tropical AKI has variable outcomes (e.g., better for volume-responsive cases, worse for toxins), with recovery possible via dialysis but higher CKD risk in resource-limited settings.
Sepsis-associated AKI (SA-AKI) stems from systemic infection triggering a uniform cascade of microcirculatory dysfunction, endothelial damage, cytokine storm, oxidative stress, and tubular cell apoptosis/necrosis, even with preserved or increased renal blood flow. This results in rapid renal function decline, patchy tubular vacuolization, and frequent multiorgan involvement. SA-AKI carries graver prognosis—mortality up to 70%, prolonged ICU stays, and 30% progression to CKD, driven by sepsis severity and comorbidities. SA-AKI independently worsens survival compared to isolated AKI or sepsis
Tropical AKI exhibits distinct phenotypes driven by its varied etiologies like infections, envenomations, toxins, and obstetric issues, differing from the more uniform hospital-acquired AKI in temperate regions. These phenotypes group cases by clinical constellations, such as fever + jaundice + AKI (e.g., leptospirosis, malaria), envenomation-related AKI (e.g., snakebites), obstetric AKI, or herbal medicine-induced AKI, enabling targeted diagnostics.
Common Phenotypes
Recognizing phenotypes impacts management by guiding rapid etiology-specific interventions over generic supportive care. For instance, fever + jaundice prompts antimicrobials (e.g., doxycycline for leptospirosis), while snakebite requires antivenom and alkalinization; this speeds diagnosis, reduces delays, and improves outcomes like recovery rates in early-treated cases. In tropics, it also prioritizes public health prevention (e.g., ORS for diarrhea) amid limited RRT access.
In patients with capillary leak, hypotension, and evolving pulmonary infiltrates—suggestive of systemic leak (e.g., sepsis, SIRS)—fluid decisions hinge on distinguishing hypovolemia-induced renal hypoperfusion from leak-driven overload risking respiratory failure and intra-abdominal hypertension (IAH).
Assessment Tools
Use dynamic over static parameters to gauge fluid responsiveness, as capillary leak invalidates thresholds like CVP or lactate alone.
Early shift to de-resuscitation (diuresis/RRT) prevents overload worsening AKI via congestion/IAH, as seen in ARDS trials where conservative fluids shortened ventilation without excess RRT. In tropical contexts like dengue leak, this avoids progression to severe edema
Distinguishing infectious (secondary) TMA from primary complement-mediated TMA (aHUS) with infection as a trigger is challenging due to overlapping features and delayed confirmatory tests. Infectious TMA often shows direct endothelial damage, neuraminidase effects (e.g., in pneumococcal), or transient complement activation without genetic defects, while primary aHUS involves pathogenic variants in complement regulators (e.g., CFH, CFI in 50-60%) or low C3 with normal C4.
Diagnostic Approach
If distinction cannot be made rapidly amid severe organ damage (e.g., AKI, neuro involvement), plasma exchange (PE) is a reasonable initial therapy while awaiting results, as it improves outcomes in infection-triggered TMA (HR 0.23 for mortality) and bridges to eculizumab if needed. Not useful ~87% (except malignancy), supporting empiric use targeting cytokines/autoantibodies. Stop PE once secondary cause treated or primary confirmed.
In patients with evolving metabolic acidosis and hyperkalemia short of classical RRT indications (e.g., K+ <6.5 mEq/L , pH >7.15, no uremic symptoms), delay initiation in tropical tubulointerstitial AKI (e.g., leptospirosis, scrub typhus) where rapid reversibility is common with pathogen-specific therapy and supportive care.
Rationale for Delay – Tropical AKI phenotypes like acute tubulointerstitial nephritis often show quick renal recovery (e.g., within 48-72 hours) once infection/toxin is addressed, avoiding RRT complications (hypotension, infection) seen in 10-20% of early starts per ELAIN/AKIKI trials. Meta-analyses confirm no mortality benefit from early RRT (HR 0.96), with 30-40% spontaneous recovery in delayed arms.
Trials like AKIKI (early vs. delayed mortality 48.5% vs. 49.7%) favor delay unless life-threatening, aligning with resource-constrained tropical settings where RRT access is limited. Reassess hourly; reversibility drops if multiorgan failure emerges.
In hemodynamically unstable patients with falciparum malaria and microvascular obstruction, simple blood transfusion often fails to improve renal oxygen delivery and can paradoxically worsen microcirculatory flow by increasing blood viscosity in obstructed vessels.
Pathophysiology
Parasitized erythrocytes cytoadhere to endothelium via PfEMP1, causing capillary obstruction (seen in 84% of severe cases, higher in non-survivors: 14.9% vs 8.3% obstructed capillaries), independent of hemoglobin levels, leading to lactate elevation and tissue hypoxia.
Acute Peritoneal dialysis (APD) serves as a cornerstone for managing tropical AKI in resource-limited settings due to its simplicity, low cost, and minimal infrastructure needs. It effectively clears solutes and fluids in etiologies like malaria, leptospirosis, or snakebites, where rapid reversibility is common.
Key Advantages
Limitations and Management
PD suits hemodynamically unstable patients without peritonitis/diaphragm defects; complications (poor outflow 10%, peritonitis 9%) are manageable with rigid protocols. In tropics, it’s first-line when HD/CRRT is unavailable (e.g., 68% pediatric AKI cases), transitioning to HD post-stabilization; ISN/SYL endorse it for 3-5 day recovery in pure AKI
Among survivors of severe tropical AKI, complete renal recovery depends on factors like AKI duration/severity, nephrotoxin exposure (e.g., herbal remedies), need for RRT, residual proteinuria at discharge, and socioeconomic barriers to follow-up. Infections like leptospirosis or scrub typhus often appear “fully reversible” short-term (e.g., 70-80% normalize creatinine by 3 months), but 20-40% progress to CKD stage 3+ within 1-2 years due to undetected nephron loss from interstitial fibrosis or vascular damage.
Long-term nephron loss is underestimated in 30-50% of “reversible” tropical cases, as transient creatinine normalization masks subclinical damage; 1-year CKD risk triples with any RRT use per cohort studies. Routine 3-month eGFR/proteinuria screening detects this early
Very informative..
Please share such nephro critical care topics every week
Good case
Excellent
High quality evidence based explanation.
Very informative